Description

Immunoglobulin or Ig, also known as gamma globulin or immune globulin, refers to the liquid plasma component of blood that contains immunoglobulins or antibodies. They are glycoprotein molecules produced by plasma cells (white blood cells). Immunoglobulins act as a critical part of the immune response by specifically recognizing and binding to particular antigens, such as bacteria or viruses, and aiding in their destruction. The global immunoglobulin market is poised to grow by US$ 5.9 billion from 2022 to 2028, registering a CAGR of 6.1% during the forecast period, according to StrategyHelix.

The report provides up-to-date market size data for period 2018-2021 and forecast to 2028 covering key market aspects like sales value for immunoglobulin. The global immunoglobulin market is segmented on the basis of product, mode of delivery, application, end user, and region. By product, the global immunoglobulin market has been segmented into IgA, IgD, IgE, IgG, IgM. According to the research, the IgG segment had the largest share in the global immunoglobulin market. Based upon mode of delivery, the global immunoglobulin market is categorized into intravenous immunoglobulins, intramuscular immunoglobulins, subcutaneous immunoglobulins. In 2021, the intravenous immunoglobulins segment made up the largest share of revenue generated by the immunoglobulin market. On the basis of application, the global immunoglobulin market has been segmented into hypogammaglobulinemia, chronic inflammatory demyelinating polyneuropathy (CIDP), Immunodeficiency disorder, myasthenia gravis, others. Among these, the Immunodeficiency disorder segment was accounted for the highest revenue generator in 2021. By end user, the global immunoglobulin market has been segmented into homecare, hospitals & clinics. In terms of geography, the global immunoglobulin market has been segmented into North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America.

The global immunoglobulin market is highly competitive. As of 2021, the major players in the global immunoglobulin market were ADMA Biologics Inc., Bharat Serums And Vaccines Limited (BSV), Biotest AG, China Biologic Products Inc. (Shandong Taibang Biological Products Co. Ltd.), CSL Limited, Grifols S.A., Johnson & Johnson, Kedrion Biopharma Inc. (Kedrion SpA), LFB S.A., Octapharma AG, Shanghai RAAS Blood Products Co. Ltd., Takeda Pharmaceutical Company Limited. Competitive landscape gives a description of the competitive nature of the global immunoglobulin market and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.

The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the immunoglobulin market to help drive informed decision making for industry executives, policy makers, academic, and analysts.

Report Scope

Product: IgA, IgD, IgE, IgG, IgM
Mode of delivery: intravenous immunoglobulins, intramuscular immunoglobulins, subcutaneous immunoglobulins
Application: hypogammaglobulinemia, chronic inflammatory demyelinating polyneuropathy (CIDP), Immunodeficiency disorder, myasthenia gravis, others
End user: homecare, hospitals & clinics
Region: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America
Years considered: this report covers the period 2018 to 2028
Company mentioned: ADMA Biologics Inc., Bharat Serums And Vaccines Limited (BSV), Biotest AG, China Biologic Products Inc. (Shandong Taibang Biological Products Co. Ltd.), CSL Limited, Grifols S.A., Johnson & Johnson, Kedrion Biopharma Inc. (Kedrion SpA), LFB S.A., Octapharma AG, Shanghai RAAS Blood Products Co. Ltd., Takeda Pharmaceutical Company Limited

Key Benefits for Stakeholders

– Get a comprehensive picture of the global immunoglobulin market
– Pinpoint growth sectors and trends for investment

Table of Contents

Part 1. Introduction
– Scope of the study
– Study period
– Geographical scope
– Research methodology
Part 2. Immunoglobulin market overview
Part 3. Market breakdown by product
– IgA
– IgD
– IgE
– IgG
– IgM
Part 4. Market breakdown by mode of delivery
– Intravenous immunoglobulins
– Intramuscular immunoglobulins
– Subcutaneous immunoglobulins
Part 5. Market breakdown by application
– Hypogammaglobulinemia
– Chronic inflammatory demyelinating polyneuropathy (CIDP)
– Immunodeficiency disorder
– Myasthenia gravis
– Others
Part 6. Market breakdown by end user
– Homecare
– Hospitals & clinics
Part 7. Market breakdown by region
– North America
– Europe
– Asia-Pacific
– MEA (Middle East and Africa)
– Latin America
Part 8. Key companies
– ADMA Biologics Inc.
– Bharat Serums And Vaccines Limited (BSV)
– Biotest AG
– China Biologic Products, Inc. (Shandong Taibang Biological Products Co., Ltd.)
– CSL Limited
– Grifols, S.A.
– Johnson & Johnson
– Kedrion Biopharma Inc. (Kedrion SpA)
– LFB S.A.
– Octapharma AG
– Shanghai RAAS Blood Products Co., Ltd.
– Takeda Pharmaceutical Company Limited
About StrategyHelix
Disclaimer